Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 611

1.

Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.

Burnett AL, Strong TD, Trock BJ, Jin L, Bivalacqua TJ, Musicki B.

J Urol. 2009 Jan;181(1):245-51. doi: 10.1016/j.juro.2008.09.005. Epub 2008 Nov 14.

PMID:
19013603
2.

The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction.

Konstantinopoulos A, Giannitsas K, Athanasopoulos A, Spathas D, Perimenis P.

Expert Opin Pharmacother. 2009 Feb;10(2):155-60. doi: 10.1517/14656560802678211 .

PMID:
19236190
3.

Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.

Vardi Y, Appel B, Ofer Y, Greunwald I, Dayan L, Jacob G.

J Urol. 2009 Dec;182(6):2850-5. doi: 10.1016/j.juro.2009.08.025. Epub 2009 Oct 17.

PMID:
19837434
4.

Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.

Morano S, Mandosi E, Fallarino M, Gatti A, Tiberti C, Sensi M, Gandini L, Buchetti B, Lenti L, Jannini EA, Lenzi A.

Eur Urol. 2007 Dec;52(6):1768-74. Epub 2007 Apr 25.

PMID:
17478034
5.

Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.

Aversa A, Vitale C, Volterrani M, Fabbri A, Spera G, Fini M, Rosano GM.

Diabet Med. 2008 Jan;25(1):37-44. doi: 10.1111/j.1464-5491.2007.02298.x.

PMID:
18199130
6.

Chronic sildenafil in men with diabetes and erectile dysfunction.

Aversa A, Bruzziches R, Vitale C, Marazzi G, Francomano D, Barbaro G, Spera G, Rosano GM.

Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):451-64. Review.

PMID:
17539751
7.

Daily use of sildenafil improves endothelial function in men with type 2 diabetes.

Deyoung L, Chung E, Kovac JR, Romano W, Brock GB.

J Androl. 2012 Mar-Apr;33(2):176-80. doi: 10.2164/jandrol.111.013367. Epub 2011 Jun 16.

PMID:
21680809
9.

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus.

Boulton AJ, Selam JL, Sweeney M, Ziegler D.

Diabetologia. 2001 Oct;44(10):1296-301.

PMID:
11692178
11.

Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.

Mathers MJ, Klotz T, Brandt AS, Roth S, Sommer F.

BJU Int. 2008 May;101(9):1129-34. doi: 10.1111/j.1464-410X.2007.07376.x. Epub 2008 Jan 10.

PMID:
18190629
12.

The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.

Pegge NC, Twomey AM, Vaughton K, Gravenor MB, Ramsey MW, Price DE.

Diabet Med. 2006 Aug;23(8):873-8.

PMID:
16911625
13.

Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction.

De Young L, Yu D, Bateman RM, Brock GB.

J Androl. 2004 Sep-Oct;25(5):830-6.

PMID:
15292117
14.
16.

Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.

Buvat J, Hatzichristou D, Maggi M, Farmer I, Martínez-Jabaloyas JM, Miller PJ, Schnetzler G.

BJU Int. 2008 Dec;102(11):1645-50. doi: 10.1111/j.1464-410X.2008.07908.x. Epub 2008 Aug 14.

PMID:
18710446
17.

[Effects of sildenafil on erectile dysfunction in the aged men with diabetes].

He ZJ, Jin J, Zhang K.

Zhonghua Nan Ke Xue. 2005 Nov;11(11):841-2, 846. Chinese.

PMID:
16333965
18.

Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose.

McCullough AR, Steidle CP, Klee B, Tseng LJ.

Urology. 2008 Apr;71(4):686-92. doi: 10.1016/j.urology.2007.12.025.

PMID:
18387397
19.

Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.

Safarinejad MR, Kolahi AA, Ghaedi G.

BJU Int. 2009 Aug;104(3):376-83. doi: 10.1111/j.1464-410X.2009.08560.x. Epub 2009 Apr 15.

PMID:
19389004
20.

Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.

Schäfer A, Fraccarollo D, Pförtsch S, Flierl U, Vogt C, Pfrang J, Kobsar A, Renné T, Eigenthaler M, Ertl G, Bauersachs J.

Br J Pharmacol. 2008 Mar;153(5):886-93. Epub 2007 Sep 24.

PMID:
17891166

Supplemental Content

Support Center